Generic Pharmaceuticals Market Report 2023

Generic Pharmaceuticals Global Market Report 2023 – By Therapy (CNS, Cardiovascular, Dermatology, Genitourinary/Harmonal, Respiratory, Rheumatology, Diabetes, Oncology), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Type (Biosimilar, Simple Generic, Super Generic), By Drug Delivery (Oral, Inectables, Dermal/Topical, Inhaler) – Market Size, Trends, And Global Forecast 2023-2032

Starting Price : $5000.00 | Pages : 250 | Published : January 2023 | Delivery Time: 2-3 business days | Format :

Need assistance or more information before the purchase?

Enquire Before Buying
Generic Pharmaceuticals Market

Proud Members Of

Generic pharmaceuticals refer to a drug that was developed to have the same dosage form, safety, strength, mode of administration, quality, performance attributes, and intended use as an already marketed brand-name drug. The action and clinical benefits of a generic drug are identical to those of a brand-name drug.

The three main types of generic pharmaceuticals are biosimilar; simple generic, and super generic. A biosimilar is a biological product that is very similar to a reference biologic and has no clinically significant differences in terms of safety, purity, or potency. The drugs are delivered through oral, injectable, dermal/topical, and inhalers that are used for various therapies such as CNS, cardiovascular, dermatology, genitourinary/hormonal, respiratory, rheumatology, diabetes, and oncology. The various distribution channels involved is hospital pharmacies, retail pharmacies, and online pharmacies.

The global generic pharmaceuticals market is segmented -

1) By Therapy: CNS, Cardiovascular, Dermatology, Genitourinary/Harmonal, Respiratory, Rheumatology, Diabetes, Oncology

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

3) By Type: Biosimilar, Simple Generic, Super Generic

4) By Drug Delivery: Oral, Inectables, Dermal/Topical, Inhaler

The global generic pharmaceuticals market size grew from $332.43 billion in 2022 to $358.5 billion in 2023 at a compound annual growth rate (CAGR) of 7.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of global generic pharmaceuticals is expected to grow from $453.19 billion in 2027 at a CAGR of 6.0%.

The rising incidence of chronic diseases is one of the major drivers of the generic pharmaceuticals market. As more individuals are diagnosed with chronic diseases, they look for more medicines for treatment. Branded drugs come at a premium price, while generic drugs are available at a lower cost and have the same chemical composition as branded drugs. The low cost and same chemical composition and strength of generic drugs make a patient buy generic drugs instead of branded drugs. If it is a chronic disease, the treatment goes on for a longer period, and hence, the sales of generic drugs also increase. For instance, according to the WHO (World Health Organization), over the next 10 years, the number of deaths due to chronic disease is projected to increase by 17%. Also, in 2020, almost 3-quarters of all deaths in the world are due to chronic diseases.

Major players in the generic pharmaceuticals market are Teva Pharmaceuticals, Mylan NV, Sandoz International GmbH, Hospira (Pfizer Inc.), Sun Pharmaceutical, Lupin Limited, Endo International PLC., Dr Reddy's Laboratories, Apotex Holdings, Fresenius Kabi Ag, Aurbindo Pharma, Aspen Pharmacare, Sanofi, Cipla, Hikma Pharmaceuticals, Stada Arzneimittel, Krka Group, Nichi-Iko Pharmaceutical, Valeant, Zydus Cadila, Merck & Co., Mitsubishi Tanabe Pharma, Momenta Pharmaceuticals, Nexus Pharmaceuticals, Novo Nordisk, Ranbaxy Laboratories Ltd., Sawai Pharmaceuticals, Novartis AG, Pfizer and Johnson & Johnson Services.

The lack of awareness about generic drugs is one of the restraints on the generic pharmaceuticals market. The high marketing and advertisement of branded drugs overshadow the availability of generic drugs, which are a substitute for expensive branded drugs. Thus, consumers opt for branded drugs even though the generic drugs carry the same chemical formulation as their counter-branded drugs. According to an article published on CVS HEALTH, many doctors and pharmacists preferred to offer branded drugs to their patients over generic drugs. This prevents the patients to go for generic drugs as they develop a preconceived notion of generic drugs not being on par with branded drugs. For example, according to research conducted by Sahana K Hebbar, in the International Journal of Basic & Clinical Pharmacology, out of 100 patients and 50 non-medical staff, 95% of the patients and 60% of the non-medical staff didn't know about generic drugs. Thus, a lack of awareness about the availability of generic drugs hampers the generic pharmaceuticals market.

3D printing technology can transform the manufacturing of drugs in the generic pharmaceuticals market. 3D printed pharmaceuticals help improve R&D productivity and deliver new benefits to patients. 3D printing allows the manufacturer to produce drugs with customised size, shape, and texture, which is not possible in traditional manufacturing of generic drugs. 3D printing can help the manufacturer to make generic drugs that have different release dates, appearances, and tastes. For example, GlaxoSmithKline (GSK) completed a study where ultraviolet (UV) and 3D printing were used to manufacture tablets to treat Parkinson's disease. Martin Wallace, director of GSK Technology, said that GSK is investing in 3D printing to manufacture pills and tablets. Also, Aprecia pharmaceutical company launched 'ZipDose' technology, which manufactures 3D printed drugs.

Drug manufacturers must comply with the CGMP (Current Good Manufacturing Practice) regulations that come under the US Food and Drug Administration (FDA) which includes generic pharmaceuticals. The CGMP regulations require manufacturers to maintain a minimum quality standard for the methods, controls, and facilities used in the manufacturing, packaging, and processing of drug products. Part- 99 of chapter 1 under title 21-Food And Drugs of CFR (Code of Federal Regulations) contains subparts from A to H. The whole part-99 describes the guidelines that need to be followed by drug manufacturers regarding the dissemination of information on human drugs, including biologics, and devices. The guidelines concern the safety, effectiveness, or benefit of use that is not included in the approved labelling for a drug or device approved by the Food and Drug Administration for marketing. The guidelines regulate the information regarding the drugs that should be delivered to the health care practitioner, pharmacy benefit manager, health insurance issuer, group health plan, or federal or state government agency.

In January 2020, ANI Pharmaceuticals, Inc., a USA-based integrated specialty pharmaceutical company focused on developing, manufacturing, and marketing high-quality branded and generic prescription pharmaceuticals, acquired Commercial and Pipeline Generic Products from American Pharmaceuticals, Ltd. for $52.5M in cash. This acquisition substantially increases ANI Pharmaceuticals, Inc.’s commercial portfolio and late-stage generic pipeline. American Pharmaceuticals is a USA-based company focused on the development, manufacture, and sale of high-quality generic pharmaceutical products.

North America was the largest region in the generic pharmaceuticals market in 2022. Middle East is expected to be the fastest-growing region in the generic pharmaceuticals market report during the forecast period. The regions covered in the generic pharmaceuticals analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The countries covered in the generic pharmaceuticals market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA.

The generic pharmaceuticals market consists of sales of paracetamol, cefixime, amoxicillin, and ofloxacin. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The generic pharmaceuticals market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the chain or as part of other products.

The generic pharmaceuticals market research report is one of a series of new reports from The Business Research Company that provides generic pharmaceuticals market statistics, including generic pharmaceuticals industry global market size, regional shares, competitors with a generic pharmaceuticals market share, detailed generic pharmaceuticals market segments, market trends and opportunities, and any further data you may need to thrive in the generic pharmaceuticals industry. The generic pharmaceuticals market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

    Table Of Contents

    1. Generic Pharmaceuticals Market Executive Summary

    2. Table of Contents

    3. List of Figures

    4. List of Tables

    5. Report Structure

    6. Introduction

    6.1. Segmentation By Geography

    6.2. Segmentation By Therapy

    6.3. Segmentation By Distribution Channel

    6.4. Segmentation By Type

    6.5. Segmentation By Drug Delivery

    7. Generic Pharmaceuticals Market Characteristics

    7.1. Segmentation By Therapy

    7.1.1. CNS

    7.1.2. Cardiovascular

    7.1.3. Dermatology

    7.1.4. Genitourinary/Harmonal

    7.1.5. Respiratory

    7.1.6. Rheumatology

    7.1.7. Diabetes

    7.1.8. Oncology

    7.1.9. Biosimilars

    7.1.10. Others

    7.2. Segmentation By Distribution Channel

    7.2.1. Hospital Pharmacies

    7.2.2. Retail Pharmacies

    7.2.3. Online Pharmacies

    7.3. Segmentation By Type

    7.3.1. Biosimilar

    7.3.2. Generics

    7.4. Segmentation By Drug Delivery Method

    7.4.1. Oral

    7.4.2. Injectables

    7.4.3. Dermal/Topical

    7.4.4. Inhaled

    8. Generic Pharmaceuticals Market Trends And Strategies

    8.1. Use of Biomarkers for Drug Development

    8.2. New Product Launches

    8.3. Investment in Artificial Intelligence

    8.4. Collaboration Driving Innovation

    8.5. Combination Drug Therapy

    8.6. 3D Printing Technology

    8.7. Modification Of Existing Epilepsy Drugs

    8.8. Rise Of Generic Respiratory Drugs

    9. Impact Of COVID-19 On Generic Pharmaceuticals Market

    9.1. Introduction

    9.2. Impact Of COVID-19 on Supply Chain Issues

    9.3. Impact Of COVID-19 Leading To Induced Demand And Panic Buying

    9.4. Impact Of COVID-19 On Companies

    9.5. Future Outlook

    10. Global Generic Pharmaceuticals Market Size And Growth

    10.1. Market Size

    10.2. Historic Market Growth, 2015 – 2020, Value ($ Million)

    10.2.1. Drivers Of The Market 2015 – 2020

    10.2.2. Restraints On The Market 2015 – 2020

    10.3.Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

    10.3.1. Drivers Of The Market 2020 – 2025

    10.3.2. Restraints On The Market 2020 – 2025

    11. Global Generic Pharmaceuticals Market Segmentation

    11.1. Global Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    11.2. Global Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    11.3. Global Generic Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    11.4.Global Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    12. Generic Pharmaceuticals Market, Regional And Country Analysis

    12.1. Global Generic Pharmaceuticals Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    12.2. Global Generic Pharmaceuticals Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    13. Asia-Pacific Generic Pharmaceuticals Market

    13.1. Asia-Pacific Generic Pharmaceuticals Market Overview

    13.1.1. Region Information

    13.1.2. Market Information

    13.1.3. Background Information

    13.1.4. Government Initiatives

    13.1.5. Regulations

    13.1.6. Regulatory Bodies

    13.1.7. Major Associations

    13.1.8. Taxes Levied

    13.1.9. Corporate Tax Structure

    13.1.10. Investments

    13.1.11. Major Companies

    13.2. Asia-Pacific Generic Pharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    13.3. Asia-Pacific Generic Pharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

    13.4.Asia-Pacific Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    13.5. Asia-Pacific Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    13.6.Asia-Pacific Generic Pharmaceuticals Market: Country Analysis

    13.7. China Generic Pharmaceuticals Market

    13.8.China Generic Pharmaceuticals Market Overview

    13.8.1. Country Information

    13.8.2. Market Information

    13.8.3. Background Information

    13.8.4. Government Initiatives

    13.8.5. Regulations

    13.8.6. Regulatory Bodies

    13.8.7. Major Associations

    13.8.8. Taxes Levied

    13.8.9. Corporate Tax Structure

    13.8.10. Investments

    13.8.11. Major Companies

    13.9.China Generic Pharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    13.10. China Generic Pharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

    13.11. China Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    13.12. China Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    13.13. India Generic Pharmaceuticals Market

    13.14. India Generic Pharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    13.15. India Generic Pharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

    13.16. India Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    13.17. India Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    13.18. Japan Generic Pharmaceuticals Market

    13.19. Japan Generic Pharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    13.20. Japan Generic Pharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

    13.21. Japan Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    13.22. Japan Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    13.23. Australia Generic Pharmaceuticals Market

    13.24. Australia Generic Pharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    13.25. Australia Generic Pharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

    13.26. Australia Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    13.27. Australia Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    13.28. Indonesia Generic Pharmaceuticals Market

    13.29. Indonesia Generic Pharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    13.30. Indonesia Generic Pharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

    13.31. Indonesia Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    13.32. Indonesia Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    13.33. South Korea Generic Pharmaceuticals Market

    13.34. South Korea Generic Pharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    13.35. South Korea Generic Pharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

    13.36. South Korea Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    13.37. South Korea Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    14. Western Europe Generic Pharmaceuticals Market

    14.1.Western Europe Generic Pharmaceuticals Market Overview

    14.1.1. Region Information

    14.1.2. Market Information

    14.1.3. Background Information

    14.1.4. Government Initiatives

    14.1.5. Regulations

    14.1.6. Regulatory Bodies

    14.1.7. Major Associations

    14.1.8. Taxes Levied

    14.1.9. Corporate Tax Structure

    14.1.10. Investments

    14.1.11. Major Companies

    14.2. Western Europe Generic Pharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    14.3.Western Europe Generic Pharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

    14.4. Western Europe Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    14.5. Western Europe Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    14.6. Western Europe Generic Pharmaceuticals Market: Country Analysis

    14.7. UK Generic Pharmaceuticals Market

    14.8. UK Generic Pharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    14.9. UK Generic Pharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

    14.10. UK Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    14.11. UK Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    14.12. Germany Generic Pharmaceuticals Market

    14.13. Germany Generic Pharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    14.14. Germany Generic Pharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

    14.15. Germany Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    14.16. Germany Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    14.17. France Generic Pharmaceuticals Market

    14.18. France Generic Pharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    14.19. France Generic Pharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

    14.20. France Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    14.21. France Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    15. Eastern Europe Generic Pharmaceuticals Market

    15.1. Eastern Europe Generic Pharmaceuticals Market Overview

    15.1.1. Region Information

    15.1.2. Market Information

    15.1.3. Background Information

    15.1.4. Government Initiatives

    15.1.5. Regulations

    15.1.6. Regulatory Bodies

    15.1.7. Major Associations

    15.1.8. Taxes Levied

    15.1.9. Corporate Tax Structure

    15.1.10. Investments

    15.1.11. Major Companies

    15.2. Eastern Europe Generic Pharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    15.3. Eastern Europe Generic Pharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

    15.4. Eastern Europe Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    15.5. Eastern Europe Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    15.6. Eastern Europe Generic Pharmaceuticals Market: Country Analysis

    15.7. Russia Generic Pharmaceuticals Market

    15.8. Russia Generic Pharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    15.9. Russia Generic Pharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

    15.10. Russia Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    15.11. Russia Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    16. North America Generic Pharmaceuticals Market

    16.1.North America Generic Pharmaceuticals Market Overview

    16.1.1. Region Information

    16.1.2. Market Information

    16.1.3. Background Information

    16.1.4. Government Initiatives

    16.1.5. Regulations

    16.1.6. Regulatory Bodies

    16.1.7. Major Associations

    16.1.8. Taxes Levied

    16.1.9. Corporate Tax Structure

    16.1.10. Investments

    16.1.11. Major Companies

    16.2. North America Generic Pharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    16.3.North America Generic Pharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

    16.4. North America Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    16.5. North America Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    16.6. North America Generic Pharmaceuticals Market: Country Analysis

    16.7. USA Generic Pharmaceuticals Market

    16.8. USA Generic Pharmaceuticals Market Overview

    16.8.1. Country Information

    16.8.2. Market Information

    16.8.3. Background Information

    16.8.4. Government Initiatives

    16.8.5. Regulations

    16.8.6. Regulatory Bodies

    16.8.7. Major Associations

    16.8.8. Taxes Levied

    16.8.9. Corporate Tax Structure

    16.8.10.Investments

    16.8.11. Major Companies

    16.9. USA Generic Pharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    16.10. USA Generic Pharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

    16.11. USA Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    16.12. USA Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    17. South America Generic Pharmaceuticals Market

    17.1. South America Generic Pharmaceuticals Market Overview

    17.1.1. Region Information

    17.1.2. Market Information

    17.1.3. Background Information

    17.1.4. Government Initiatives

    17.1.5. Regulations

    17.1.6. Regulatory Bodies

    17.1.7. Major Associations

    17.1.8. Taxes Levied

    17.1.9. Corporate Tax Structure

    17.1.10. Investments

    17.1.11. Major Companies

    17.2. South America Generic Pharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    17.3. South America Generic Pharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

    17.4. South America Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    17.5. South America Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    17.6. South America Generic Pharmaceuticals Market: Country Analysis

    17.7. Brazil Generic Pharmaceuticals Market

    17.8. Brazil Generic Pharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    17.9. Brazil Generic Pharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

    17.10. Brazil Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    17.11. Brazil Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    18. Middle East Generic Pharmaceuticals Market

    18.1. Middle East Generic Pharmaceuticals Market Overview

    18.1.1. Region Information

    18.1.2. Market Information

    18.1.3. Background Information

    18.1.4. Government Initiatives

    18.1.5. Regulations

    18.1.6. Regulatory Bodies

    18.1.7. Major Associations

    18.1.8. Taxes Levied

    18.1.9. Corporate Tax Structure

    18.1.10. Investments

    18.1.11. Major Companies

    18.2. Middle East Generic Pharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    18.3.Middle East Generic Pharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

    18.4. Middle East Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    18.5. Middle East Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    19. Africa Generic Pharmaceuticals Market

    19.1.Africa Generic Pharmaceuticals Market Overview

    19.1.1. Region Information

    19.1.2. Market Information

    19.1.3. Background Information

    19.1.4. Government Initiatives

    19.1.5. Regulations

    19.1.6. Regulatory Bodies

    19.1.7. Major Associations

    19.1.8. Taxes levied

    19.1.9. Corporate Tax Structure

    19.1.10. Investments

    19.1.11. Major Companies

    19.2. Africa Generic Pharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    19.3.Africa Generic Pharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

    19.4. Africa Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    19.5. Africa Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    20. Generic Pharmaceuticals Global Market Competitive Landscape

    20.1. Company Profiles

    20.2. Teva Pharmaceutical Industries Ltd.

    20.2.1. Company Overview

    20.2.2. Products And Services

    20.2.3. Business Strategy

    20.2.4. Financial Overview

    20.3. Novartis AG

    20.3.1. Company Overview

    20.3.2. Products And Services

    20.3.3. Business Strategy

    20.3.4. Financial Overview

    20.4. Viatris Inc.

    20.4.1. Company Overview

    20.4.2. Products And Services

    20.4.3. Business Strategy

    20.4.4. Financial Overview

    20.5. Sun Pharmaceutical Industries Ltd.

    20.5.1. Company Overview

    20.5.2. Products And Services

    20.5.3. Business Strategy

    20.5.4. Financial Overview

    20.6. Fresenius Kabi

    20.6.1. Company Overview

    20.6.2. Products And Services

    20.6.3. Business Strategy

    20.6.4. Financial Overview

    21. Key Mergers And Acquisitions In The Generic Pharmaceuticals Market

    21.1. Carlyle Acquired Viyash Life Sciences

    21.2. Sandoz Acquired GSK’s Cephalosporin Antibiotics Business

    21.3. ANI Pharmaceuticals, Inc. Acquired Novitium Pharma

    21.4. Mylan NV Merged With Viatris

    21.5. Sun Pharmaceutical Industries Acquired Aquinox Pharmaceuticals Inc.

    21.6. ANI Pharmaceuticals, Inc. Acquired Amerigen Pharmaceuticals, Ltd. Generic Products

    21.7. Sandoz Acquired Aspen Global Incorporated (AGI)

    21.8. Teva Pharmaceutical Industries Ltd. Acquired Allergan plc

    21.9. Sun Pharma Acquired Ranbaxy Laboratories

    21.10. Pfizer Inc. Merged With Hospira, Inc.

    22. Generic Pharmaceuticals Market Future Outlook and Potential Analysis

    22.1. Global Generic Pharmaceuticals Market In 2025 – Countries Offering Most New Opportunities

    22.2. Global Generic Pharmaceuticals Market In 2025 – Segments Offering Most New Opportunities

    22.3. Global Generic Pharmaceuticals Market In 2025 – Growth Strategies

    22.3.1. Market Trend Based Strategies

    22.3.2. Competitor Strategies

    23. Appendix

    23.1. Market Data Sources

    23.2. NAICS Definitions Of Industry Covered In This Report

    23.3.Research Methodology

    23.4. Abbreviations

    23.5. Currencies

    23.6. Research Inquiries

    23.7. The Business Research Company

    23.8. Copyright And Disclaimer

List Of Tables

    Table 1: Global Generic Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
  • Table 2: Global Generic Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 3: Global Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 4: Global Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 5: Global Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 6: Global Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 7: Global Generic Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 8: Global Generic Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 9: Global Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 10: Global Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 11: Global Generic Pharmaceuticals Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 12: Global Generic Pharmaceuticals Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 13: Global Generic Pharmaceuticals Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 14: Global Generic Pharmaceuticals Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 15: Asia-Pacific Public Healthcare Expenditure, 2015-2020, $ Billion
  • Table 16:  Asia-Pacific Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 17: Asia-Pacific, Population By Age Group, By Country, 2015-2025, Thousands
  • Table 18: Asia Pacific Healthcare Services Market Size, Historic And Forecast, 2015-2020, 2020-2025F, 2030F
  • Table 19: Asia Pacific GDP Per Capita, 2015-2020, $
  • Table 20: Asia-Pacific Generic Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
  • Table 21: Asia-Pacific Generic Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 22: Asia-Pacific Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 23: Asia-Pacific Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 24: Asia-Pacific Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 25: Asia-Pacific Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 26:  China Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 27: China, Population By Age Group, 2015-2025, Thousands
  • Table 28: China Healthcare Services Market Size, Historic And Forecast, 2015-2020, 2020-2025F, 2030F
  • Table 29: China GDP Per Capita, 2015-2020, $
  • Table 30: China Generic Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
  • Table 31: China Generic Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 32: China Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 33: China Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 34: China Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 35: China Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 36: India Generic Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
  • Table 37: India Generic Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 38: India Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 39: India Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 40: India Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 41: India Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 42: Japan Generic Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
  • Table 43: Japan Generic Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 44: Japan Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 45: Japan Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 46: Japan Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 47: Japan Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 48: Australia Generic Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
  • Table 49: Australia Generic Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 50: Australia Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 51: Australia Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 52: Australia Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 53: Australia Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 54: Indonesia Generic Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
  • Table 55: Indonesia Generic Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 56: Indonesia Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 57: Indonesia Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 58: Indonesia Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 59: Indonesia Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 60: South Korea Generic Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
  • Table 61: South Korea Generic Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 62: South Korea Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 63: South Korea Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 64: South Korea Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 65: South Korea Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 66:  Western Europe Public Healthcare Expenditure, 2015-2020, $ Billion
  • Table 67:  Western Europe Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 68: Western Europe, Population By Age Group, By Country, 2015-2025, Thousands
  • Table 69: Western Europe Healthcare Services Market Size, Historic And Forecast, 2015-2020, 2020-2025F, 2030F
  • Table 70: Western Europe GDP Per Capita, 2015-2020, $
  • Table 71: Western Europe Generic Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
  • Table 72: Western Europe Generic Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 73: Western Europe Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 74: Western Europe Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 75: Western Europe Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 76: Western Europe Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 77: UK Generic Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
  • Table 78: UK Generic Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 79: UK Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 80: UK Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 81: UK Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 82: UK Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 83: Germany Generic Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
  • Table 84: Germany Generic Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 85: Germany Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 86: Germany Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 87: Germany Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 88: Germany Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 89: France Generic Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
  • Table 90: France Generic Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 91: France Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 92: France Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 93: France Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 94: France Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 95:  Eastern Europe Public Healthcare Expenditure, 2015-2020, $ Billion
  • Table 96:  Eastern Europe Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 97: Eastern Europe, Population By Age Group, By Country, 2015-2025, Thousands
  • Table 98: Eastern Europe Healthcare Services Market Size, Historic And Forecast, 2015-2020, 2020-2025F, 2030F
  • Table 99: Eastern Europe GDP Per Capita, 2015-2020, $
  • Table 100: Eastern Europe Generic Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
  • Table 101: Eastern Europe Generic Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 102: Eastern Europe Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 103: Eastern Europe Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 104: Eastern Europe Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 105: Eastern Europe Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 106: Russia Generic Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
  • Table 107: Russia Generic Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 108: Russia Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 109: Russia Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 110: Russia Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 111: Russia Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 112:  North America Public Healthcare Expenditure, 2015-2020, $ Billion
  • Table 113:  North America Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 114: North America, Population By Age Group, By Country, 2015-2025, Thousands
  • Table 115: North America Healthcare Services Market Size, Historic And Forecast, 2015-2020, 2020-2025F, 2030F
  • Table 116: North America GDP Per Capita, 2015-2020, $
  • Table 117: North America Generic Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
  • Table 118: North America Generic Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 119: North America Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 120: North America Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 121: North America Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 122: North America Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 123:  USA Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 124: USA, Population By Age Group, 2015-2025, Thousands
  • Table 125: USA Healthcare Services Market Size, Historic And Forecast, 2015-2020, 2020-2025F, 2030F
  • Table 126: USA GDP Per Capita, 2015-2020, $
  • Table 127: USA Generic Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
  • Table 128: USA Generic Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 129: USA Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 130: USA Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 131: USA Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 132: USA Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 133:  South America Public Healthcare Expenditure, 2015-2020, $ Billion
  • Table 134:  South America Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 135: South America, Population By Age Group, By Country, 2015-2025, Thousands
  • Table 136: South America Healthcare Services Market Size, Historic And Forecast, 2015-2020, 2020-2025F, 2030F
  • Table 137: South America GDP Per Capita, 2015-2020, $
  • Table 138: South America Generic Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
  • Table 139: South America Generic Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 140: South America Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 141: South America Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 142: South America Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 143: South America Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 144: Brazil Generic Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
  • Table 145: Brazil Generic Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 146: Brazil Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 147: Brazil Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 148: Brazil Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 149: Brazil Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 150:  Middle East Public Healthcare Expenditure, 2015-2020, $ Billion
  • Table 151:  Middle East Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 152: Middle East, Population By Age Group, By Country, 2015-2025, Thousands
  • Table 153: Middle East Healthcare Services Market Size, Historic And Forecast, 2015-2020, 2020-2025F, 2030F
  • Table 154: Middle East GDP Per Capita, 2015-2020, $
  • Table 155: Middle East Generic Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
  • Table 156: Middle East Generic Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 157: Middle East Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 158: Middle East Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 159: Middle East Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 160: Middle East Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 161:  Africa Public Healthcare Expenditure, 2015-2020, $ Billion
  • Table 162:  Africa Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 163: Africa, Population By Age Group, By Country, 2015-2025, Thousands
  • Table 164: Africa Healthcare Services Market Size, Historic And Forecast, 2015-2020, 2020-2025F, 2030F
  • Table 165: Africa GDP Per Capita, 2015-2020, $
  • Table 166: Africa Generic Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
  • Table 167: Africa Generic Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 168: Africa Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 169: Africa Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 170: Africa Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 171: Africa Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 172: Global Generic Pharmaceuticals Market, Key Competitor Estimated Market Shares, 2020, Percentage (%)
  • Table 173: Teva Pharmaceutical Industries Ltd. – Financial Overview, 2016 - 2020, $ Billion
  • Table 174: Novartis AG – Financial Performance, 2016 – 2020, $ Billion
  • Table 175: Viatris Inc. – Financial Performance, 2016 – 2020, $ Billion
  • Table 176: Sun Pharmaceutical Industries Ltd. – Financial Overview, 2016 - 2020, $ Billion
  • Table 177: Fresenius Kabi  – Financial Overview, 2016 - 2020, $ Billion
  • Table 178: Global Generic Pharmaceuticals Market Size Gain ($ Million), 2020 – 2025, By Country
  • Table 179: Global Generic Pharmaceuticals Market Size Gain ($ Million), Segmentation By Therapy, 2020 – 2025
  • Table 180: Global Generic Pharmaceuticals Market Size Gain ($ Million), Segmentation By Distribution Channel, 2020 – 2025
  • Table 181: Global Generic Pharmaceuticals Market Size Gain ($ Million), Segmentation By Type, 2020 – 2025
  • Table 182: Global Generic Pharmaceuticals Market Size Gain ($ Million), Segmentation By Drug Delivery, 2020 – 2025
  • Table 183: Generic Pharmaceuticals - Market Data Sources

List Of Figures

    Figure 1: Global Generic Pharmaceuticals Market Segmentation By Therapy
  • Figure 2: Global Generic Pharmaceuticals Market Segmentation By Distribution Channel
  • Figure 3: Global Generic Pharmaceuticals Market Segmentation By Type
  • Figure 4: Global Generic Pharmaceuticals Market Segmentation By Drug Delivery
  • Figure 5: Global Generic Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
  • Figure 6: Global Generic Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 7: Global Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 8: Global Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 9: Global Generic Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 10: Global Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 11: Global Generic Pharmaceuticals Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 12: Global Generic Pharmaceuticals Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 13: Asia-Pacific Generic Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
  • Figure 14: Asia-Pacific Generic Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 15: Asia-Pacific Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 16: Asia-Pacific Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 17: China Generic Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
  • Figure 18: China Generic Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 19: China Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 20: China Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 21: India Generic Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
  • Figure 22: India Generic Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 23: India Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 24: India Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 25: Japan Generic Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
  • Figure 26: Japan Generic Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 27: Japan Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 28: Japan Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 29: Australia Generic Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
  • Figure 30: Australia Generic Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 31: Australia Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 32: Australia Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 33: Indonesia Generic Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
  • Figure 34: Indonesia Generic Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 35: Indonesia Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 36: Indonesia Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 37: South Korea Generic Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
  • Figure 38: South Korea Generic Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 39: South Korea Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 40: South Korea Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 41: Western Europe Generic Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
  • Figure 42: Western Europe Generic Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 43: Western Europe Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 44: Western Europe Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 45: UK Generic Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
  • Figure 46: UK Generic Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 47: UK Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 48: UK Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 49: Germany Generic Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
  • Figure 50: Germany Generic Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 51: Germany Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 52: Germany Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 53: France Generic Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
  • Figure 54: France Generic Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 55: France Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 56: France Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 57: Eastern Europe Generic Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
  • Figure 58: Eastern Europe Generic Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 59: Eastern Europe Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 60: Eastern Europe Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 61: Russia Generic Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
  • Figure 62: Russia Generic Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 63: Russia Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 64: Russia Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 65: North America Generic Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
  • Figure 66: North America Generic Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 67: North America Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 68: North America Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 69: USA Generic Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
  • Figure 70: USA Generic Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 71: USA Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 72: USA Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 73: South America Generic Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
  • Figure 74: South America Generic Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 75: South America Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 76: South America Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 77: Brazil Generic Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
  • Figure 78: Brazil Generic Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 79: Brazil Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 80: Brazil Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 81: Middle East Generic Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
  • Figure 82: Middle East Generic Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 83: Middle East Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 84: Middle East Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 85: Africa Generic Pharmaceuticals Market, Historic, 2015 – 2020, $ Million
  • Figure 86: Africa Generic Pharmaceuticals Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 87: Africa Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 88: Africa Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 89: Global Generic Pharmaceuticals Market, Key Competitor Estimated Market Shares, 2020, Percentage (%)
  • Figure 90: Teva Pharmaceutical Industries Ltd. – Financial Overview, 2016 – 2020, $ Billion
  • Figure 91: Novartis AG – Financial Performance, 2016 – 2020, $ Billion
  • Figure 92: Viatris Inc. – Financial Performance, 2016 – 2020, $ Billion
  • Figure 93: Sun Pharmaceutical Industries Ltd. – Financial Overview, 2016 – 2020, $ Billion
  • Figure 94: Fresenius Kabi – Financial Overview, 2016 – 2020, $ Billion
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report